Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Impact of therapy on the long-term outcome of chronic hepatitis B.

Liaw YF.

Clin Liver Dis. 2013 Aug;17(3):413-23. doi: 10.1016/j.cld.2013.05.005. Epub 2013 Jun 21. Review.

PMID:
23905813
2.

Short- and long-term outcome of interferon therapy for chronic hepatitis B infection.

Seo Y, Yano Y.

World J Gastroenterol. 2014 Oct 7;20(37):13284-92. doi: 10.3748/wjg.v20.i37.13284. Review.

3.

Prevention of hepatocellular carcinoma in hepatitis B virus infection.

Lim SG, Mohammed R, Yuen MF, Kao JH.

J Gastroenterol Hepatol. 2009 Aug;24(8):1352-7. doi: 10.1111/j.1440-1746.2009.05985.x. Review.

PMID:
19702903
4.

Impact of hepatitis B therapy on the long-term outcome of liver disease.

Liaw YF.

Liver Int. 2011 Jan;31 Suppl 1:117-21. doi: 10.1111/j.1478-3231.2010.02388.x. Review.

PMID:
21205148
5.

Impact of therapy on the outcome of chronic hepatitis B.

Liaw YF.

Liver Int. 2013 Feb;33 Suppl 1:111-5. doi: 10.1111/liv.12057. Review.

PMID:
23286854
6.

Antiviral therapy for chronic hepatitis B.

Jafri SM, Lok AS.

Clin Liver Dis. 2010 Aug;14(3):425-38. doi: 10.1016/j.cld.2010.05.005. Review.

PMID:
20638023
7.

Long-term outcome of hepatitis B virus-related Chronic Hepatitis under protracted nucleos(t)ide analogues.

Niro GA, Ippolito AM, Fontana R, Valvano MR, Gioffreda D, Iacobellis A, Merla A, Durazzo M, Lotti G, Di Mauro L, Andriulli A.

J Viral Hepat. 2013 Jul;20(7):502-9. doi: 10.1111/jvh.12054. Epub 2013 Feb 6.

PMID:
23730844
8.

Does antiviral therapy for chronic hepatitis B reduce the risk of hepatocellular carcinoma?

Abu-Amara M, Feld JJ.

Semin Liver Dis. 2013 May;33(2):157-66. doi: 10.1055/s-0033-1345719. Epub 2013 Jun 8. Review.

PMID:
23749672
9.

Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence.

Tan ZM, Sun BC.

World J Gastroenterol. 2013 Dec 21;19(47):8895-901. doi: 10.3748/wjg.v19.i47.8895. Review.

10.

Natural history of chronic hepatitis B virus infection and long-term outcome under treatment.

Liaw YF.

Liver Int. 2009 Jan;29 Suppl 1:100-7. doi: 10.1111/j.1478-3231.2008.01941.x. Review.

PMID:
19207972
11.
12.

Impact of HBV therapy on the incidence of hepatocellular carcinoma.

Triolo M, Della Corte C, Colombo M.

Liver Int. 2014 Feb;34 Suppl 1:139-45. doi: 10.1111/liv.12394. Review.

PMID:
24373091
13.

Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents.

Kim CH, Um SH, Seo YS, Jung JY, Kim JD, Yim HJ, Keum B, Kim YS, Jeen YT, Lee HS, Chun HJ, Kim CD, Ryu HS.

J Gastroenterol Hepatol. 2012 Oct;27(10):1589-95. doi: 10.1111/j.1440-1746.2012.07167.x.

PMID:
22554121
14.

Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success.

Chien RN, Liaw YF.

Best Pract Res Clin Gastroenterol. 2008;22(6):1081-92. doi: 10.1016/j.bpg.2008.11.003. Review.

PMID:
19187868
15.

Management of chronic hepatitis B: status and challenges beyond treatment guidelines.

Wiegand J, van Bömmel F, Berg T.

Semin Liver Dis. 2010 Nov;30(4):361-77. doi: 10.1055/s-0030-1267537. Epub 2010 Oct 19. Review.

PMID:
20960376
16.

Management of chronic hepatitis B infection.

Sundaram V, Kowdley K.

BMJ. 2015 Oct 21;351:h4263. doi: 10.1136/bmj.h4263. Review.

17.

Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea.

Park YH, Kim BK, Kim JK, Kim HC, Kim do Y, Park JY, Han KH, Kim SU, Shin SH, Hahn KY, Ahn SH.

J Gastroenterol Hepatol. 2014 May;29(5):1005-11. doi: 10.1111/jgh.12478.

PMID:
24325579
18.

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma.

Lin SM, Yu ML, Lee CM, Chien RN, Sheen IS, Chu CM, Liaw YF.

J Hepatol. 2007 Jan;46(1):45-52. Epub 2006 Oct 20.

PMID:
17107734
19.

Antiviral Therapy in Hepatitis B Virus-Associated Liver Cirrhosis.

Boettler T, Thimme R.

Dig Dis. 2015;33(4):608-12. doi: 10.1159/000375357. Epub 2015 Jul 6.

PMID:
26159281
20.

Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?

Lok AS.

J Gastroenterol Hepatol. 2011 Feb;26(2):221-7. doi: 10.1111/j.1440-1746.2010.06576.x.

PMID:
21070361
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk